ICMR slams BHU's Covaxin study, says it wasn't part of it
Monday, 20 May 2024
Indian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR. Director Rajiv Bahl clarifies the lack of comparison group for side effects attribution. Nearly one-third of Covaxin recipients reported adverse events. ICMR warns of legal action for unapproved acknowledgements.
Indian Council of Medical Research criticizes a recently-published study on Covaxin's safety analysis for poor methodology. The study wrongly acknowledges ICMR. Director Rajiv Bahl clarifies the lack of comparison group for side effects attribution. Nearly one-third of Covaxin recipients reported adverse events. ICMR warns of legal action for unapproved acknowledgements.
|
||||
|
||||
You Might Like💡 newsR Knowledge: Other News MentionsIndian Council of Medical Research Government organizationICMR issues norms for antibiotic susceptibility testing and validationThe Indian Council for Medical Research (ICMR) has issued new protocols for testing and validation methods of antibiotic susceptibility test kits. These..IndiaTimes Related news from verified sources
|